Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
via Google News
The Latest on: Malaria vaccine
- Rwanda in talks to acquire malaria vaccineon May 27, 2022 at 8:00 am
Rwanda is taking part in discussions with several international stakeholders, as part of efforts for the country to acquire the malaria vaccine. In a ground-breaking development, in October last year, ...
- Why Did It Take 35 Years for the World To Get a Malaria Vaccine?on May 26, 2022 at 8:09 pm
The WHO approved the first malaria vaccine in October 2021 and it was hailed as a milestone. Dubbed RTS,S, it promises a 30% reduction in severe malaria in fully vaccinated children. However, the core ...
- Why did it take 35 years to get a malaria vaccine?on May 26, 2022 at 6:00 pm
The parasite’s complex biology played a role in the delay, but experts say there was also a lack of urgency and funding.
- It Took 35 Years to Get a Malaria Vaccine. Why?on May 25, 2022 at 1:35 pm
The parasite's complex biology played a role in the delay, but experts say there was also a lack of urgency and funding.
- Davos 2022: Bill Gates says Pfizer partnership will support malaria mRNA vaccine 'dream'on May 25, 2022 at 3:20 am
A partnership between US drug maker Pfizer and the Bill & Melinda Gates Foundation to speed up the development of vaccines to prevent diseases that cause newborn mortality would also advance efforts ...
- Vaccine delivers hope for families hit by malariaon May 15, 2022 at 5:08 pm
Had I known that malaria kills, I would have taken them to hospital earlier,” said the father of 15 with two wives. The first wife lost three of her 11 children while the second wife lost four of her ...
- First malaria vaccine hits 1 million dose milestone — although it has its shortcomingson May 13, 2022 at 2:17 pm
The vaccine couldn't have come at a more critical time, with a surge in cases and deaths from malaria during the pandemic. But its efficacy — and its schedule — are far from ideal.
- First malaria vaccine hits 1 million dose milestone — although it has its shortcomingson May 13, 2022 at 10:53 am
Just such a new tool arrived last fall when the WHO authorized a malaria vaccine — the first ever against a parasitic disease — to be rolled out in Ghana, Kenya and Malawi. And now it's hit a ...
- Rollout of world's first malaria jab gathers paceon May 6, 2022 at 8:35 am
The world's first malaria vaccine will soon be available across sub-Saharan Africa, according to PATH, partners of the vaccine developers, as positive results from the pioneering jab pile up.
- World's first malaria vaccine may be available soon across Sub-Saharan Africaon May 4, 2022 at 5:01 pm
The world's first malaria vaccine will soon be available across Sub-Saharan Africa, according to PATH, partners of the vaccine developers, as positive results from the pioneering jab pile up. The ...
via Bing News